跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
D-01
首页
药物
D-01
D-01
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RECOMBINANT ONCOLYTIC ADENOVIRUS FOR CANCER THERAPY
US 20260240928 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2023
US
WO
2 件公开
HUMAN T CELL RECEPTORS TARGETING TUMOR-ENHANCED SPLICING EPITOPES ON HLA-A*02:01 FOR SMALL CELL CARCINOMA
EP 4695284 A1
申请人: THE REGENTS OF UNIV OF CALIFORNIA
优先权: 2023
EP
WO
2 件公开
IGF-I poly (ethylene glycol) conjugates
US 9587006 B2
申请人: HESSE FRIEDERIKE
优先权: 2010
US
2 件公开
Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines
EP 1695964 A1
申请人: NOVEXEL
优先权: 2001
EP
Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
US 2005119259 A1
申请人: ASTRAZENECA AB
优先权: 2002
US
Combination product comprising melagatran and an anti-arrhythmic oxabispidenes
US 2006074080 A1
申请人: ASTRAZENECA AB
优先权: 2002
US
Pharmaceutical combination
US 2006052314 A1
申请人: ROTH-ROSENDAHL ANN-CHARLOTTE
优先权: 2002
US
Human parathyroid hormone modifications, preparation and use
US 2005203012 A1
申请人: GEN HOSPITAL CORP
优先权: 2004
US
BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
US 2011097357 A1
申请人: GLYCOVAXYN AG
优先权: 2009
US
Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues
US 10265372 B2
申请人: UNIV CALIFORNIA
优先权: 2015
US
第 1 / 3 页
上一页
下一页
药物
反馈